Literature DB >> 2907538

Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus.

F A De Beurme1, R A Lefebvre.   

Abstract

Relaxations were induced in longitudinal muscle strips of the rat gastric fundus by stimulation of non-adrenergic non-cholinergic (NANC) neurons and by administration of vasoactive intestinal polypeptide (VIP) or isoprenaline. The effect of antiserum against vasoactive intestinal polypeptide (VIP antiserum) and of control serum on these relaxations was investigated. Incubation with VIP antiserum (dilution 1/50) for 1 h almost completely prevented the relaxation by VIP. It partially prevented the relaxation evoked by electrical stimulation while the relaxation induced by isoprenaline was not influenced. Control serum decreased the VIP- and stimulation-induced relaxations much less than did VIP antiserum. In addition, the effect of the putative VIP antagonist (4Cl-D-Phe6, Leu17) VIP was studied on the relaxations induced by NANC neuron stimulation and by VIP. The VIP antagonist (3 x 10(-5) M, incubation time 10 min) had a relaxatory effect itself but had no influence on either VIP- or stimulation-induced relaxations. The results with VIP antiserum confirm the involvement of VIP in the inhibitory NANC neurotransmission of the rat gastric fundus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907538     DOI: 10.1111/j.2042-7158.1988.tb07000.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  14 in total

1.  Increase in participation of vasoactive intestinal peptide in relaxation of the distal colon of Wistar rats with age.

Authors:  T Takeuchi; T Negoro; M Yamaji; Y Yamazaki; A Fujita; H Nishio; T Takewaki; K Takatsuji; F Hata
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Influence of NG-nitro-L-arginine methyl ester on vagally induced gastric relaxation in the anaesthetized rat.

Authors:  R A Lefebvre; J Hasrat; A Gobert
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

3.  Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.

Authors:  Olafur S Palsson; Olivier Morteau; Eugene M Bozymski; John T Woosley; R Balfour Sartor; Michael J Davies; David A Johnson; Marsha J Turner; William E Whitehead
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  Release of vasoactive intestinal polypeptide from the rat gastric fundus.

Authors:  M D'Amato; D Currò; P Montuschi; G Ciabattoni; E Ragazzoni; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  Modulation of non-adrenergic non-cholinergic inhibitory neurotransmission in rat gastric fundus by the alpha 2-adrenoceptor agonist, UK-14,304.

Authors:  R A Lefebvre; G J Smits
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

6.  Alpha 2-adrenoceptor-mediated modulation of the nitrergic innervation of the canine isolated ileocolonic junction.

Authors:  G E Boeckxstaens; J G De Man; P A Pelckmans; A G Herman; Y M Van Maercke
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Effect of immunisation against vasoactive intestinal polypeptide on gastric corpus tone and motility in the ferret.

Authors:  D Grundy; M K Gharib-Naseri; D Hutson
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

8.  Influence of NG-nitro-L-arginine on non-adrenergic non-cholinergic relaxation in the guinea-pig gastric fundus.

Authors:  R A Lefebvre; E Baert; A J Barbier
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach.

Authors:  T Ohta; S Ito; A Ohga
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Nitric oxide, and not vasoactive intestinal peptide, as the main neurotransmitter of vagally induced relaxation of the guinea pig stomach.

Authors:  K M Desai; T D Warner; A E Bishop; J M Polak; J R Vane
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.